These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 48423)

  • 1. [Mechanism of cystostatic effect of 5-azacytidine and its usefulness in clinic].
    Veselý J; Cihák A
    Cas Lek Cesk; 1975 May; 114(20):607-11. PubMed ID: 48423
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possibilities for the clinical use of 5-azacytidine].
    Veselý J; Cihák A
    Vopr Onkol; 1977; 23(10):65-73. PubMed ID: 74127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aim of treatment in acute leukemia].
    Senn HJ
    Ther Umsch; 1969 Jul; 26(7):395-401. PubMed ID: 5257145
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-azacytidine.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():37-46. PubMed ID: 6168559
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyrazofurin enhancement of 5-azacytidine antitumor activity in L5178Y and human leukemia cells.
    Cadman E; Eiferman F; Heimer R; Davis L
    Cancer Res; 1978 Dec; 38(12):4610-7. PubMed ID: 82479
    [No Abstract]   [Full Text] [Related]  

  • 6. Comprehensive care of adult acute leukemia.
    Skeel RT; DeConti RC; Marsh JC; Mitchell MS; Bertino JR
    Conn Med; 1972 Jul; 36(7):378-82. PubMed ID: 4504918
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of acute leukemia with 5-azacytidine (NSC-102816).
    McCredie KB; Bodey GP; Burgess MA; Gutterman JU; Rodriguez V; Sullivan MP; Freireich EJ
    Cancer Chemother Rep; 1973; 57(3):319-23. PubMed ID: 4127393
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy of leukaemia.
    Malpas JS
    Schweiz Med Wochenschr; 1974 May; 104(18):626-33. PubMed ID: 4596725
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cytokinetics, chemotherapy and clinical course of acute leukemias].
    Gavosto F; Masera P; Pagliardi GL
    Minerva Med; 1975 Jul; 66(51):2534-7. PubMed ID: 1057049
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Frei E; Schabel FM; Goldin A
    Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute leukemia, 1969. A review.
    Garfinkel LS
    Mo Med; 1969 Dec; 66(12):950-3. PubMed ID: 4901107
    [No Abstract]   [Full Text] [Related]  

  • 12. [6-Thioguanine in the chemotherapy of leukemias].
    Zidermane AA
    Vopr Onkol; 1979; 25(1):74-83. PubMed ID: 284664
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group.
    Winton EF; Hearn EB; Martelo O; Presant CA; Adler S; Vogler WR; Raney M; Logan T; Silberman HM; Omura GA
    Cancer Treat Rep; 1985; 69(7-8):807-11. PubMed ID: 2410119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to the treatment of acute leukemia and lymphoma in adults.
    Bodey GP; Rodriguez V
    Semin Hematol; 1978 Jul; 15(3):221-61. PubMed ID: 353991
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations on toxicity and clinical trials with daunomycin.
    Serpick AA; Henderson ES
    Pathol Biol; 1967 Oct; 15(19):909-12. PubMed ID: 4967536
    [No Abstract]   [Full Text] [Related]  

  • 16. 5-Azacytidine: a new active agent for the treatment of acute leukemia.
    Karon M; Sieger L; Leimbrock S; Finklestein JZ; Nesbit ME; Swaney JJ
    Blood; 1973 Sep; 42(3):359-65. PubMed ID: 4125239
    [No Abstract]   [Full Text] [Related]  

  • 17. Karyotypes of the 5-azacytidine-sensitive and -resistant line of AKR mouse leukemia.
    Seifertová M
    Neoplasma; 1981; 28(3):317-23. PubMed ID: 6170003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinblastine, 5-azacytidine, and VP-16-213 therapy for previously treated patients with acute nonlymphocytic leukemia.
    Van Echo DA; Lichtenfeld KM; Wiernik PH
    Cancer Treat Rep; 1977 Nov; 61(8):1599-602. PubMed ID: 72605
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological approaches of leukaemia treatment.
    Mathé G
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):855-81. PubMed ID: 4559238
    [No Abstract]   [Full Text] [Related]  

  • 20. 5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemia.
    Von Hoff DD; Slavik M; Muggia FM
    Ann Intern Med; 1976 Aug; 85(2):237-45. PubMed ID: 60073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.